Menu
10/08/2007
Court Orders Review Of Alzheimer's Guidelines
A high court judge has ordered a review of guidelines on the way it decides which Alzheimer's patients are given three drugs to treat the brain-destroying disease.
Mrs Justice Hobbs ruled that the National Institute for Health and Clinical Excellence (NICE), the body responsible for providing advice on treatments available on the NHS, must rewrite guidance on how the disease is assessed.
It is the very first time a judicial review has been sought on NICE guidance.
Eisai, the Japanese company which makes Aricept and Pfizer, brought the case to the High Court with support from the Alzheimer's society.
The judge said: "In the light of the court's finding that the guidance is discriminatory, the court directs Nice to amend the guidance so as to ensure its compliance with Nice's duties and obligations under anti-discrimination legislation."
In a statement, Eisai and Pfizer said the court ruling was "a major victory for the many critics of the process by which NICE reaches it often seemingly clinically perverse decisions".
Andrew Dillon, chief executive of NICE said: "Our guidance stands and the drugs continue to be recommended only for people with moderate Alzheimer's disease, but the court has asked us to clarify our guidance when it is used for certain groups.
"Alzheimer's disease is a devastating illness, but the evidence indicates that these drugs are simply not effective for some patients.
"That is why we also issued advice last year on the broader support that should be provided for people with Alzheimer's disease and those who care for them, creating core standards for the NHS and care homes that will make a real difference for patients and their families."
(CD)
Mrs Justice Hobbs ruled that the National Institute for Health and Clinical Excellence (NICE), the body responsible for providing advice on treatments available on the NHS, must rewrite guidance on how the disease is assessed.
It is the very first time a judicial review has been sought on NICE guidance.
Eisai, the Japanese company which makes Aricept and Pfizer, brought the case to the High Court with support from the Alzheimer's society.
The judge said: "In the light of the court's finding that the guidance is discriminatory, the court directs Nice to amend the guidance so as to ensure its compliance with Nice's duties and obligations under anti-discrimination legislation."
In a statement, Eisai and Pfizer said the court ruling was "a major victory for the many critics of the process by which NICE reaches it often seemingly clinically perverse decisions".
Andrew Dillon, chief executive of NICE said: "Our guidance stands and the drugs continue to be recommended only for people with moderate Alzheimer's disease, but the court has asked us to clarify our guidance when it is used for certain groups.
"Alzheimer's disease is a devastating illness, but the evidence indicates that these drugs are simply not effective for some patients.
"That is why we also issued advice last year on the broader support that should be provided for people with Alzheimer's disease and those who care for them, creating core standards for the NHS and care homes that will make a real difference for patients and their families."
(CD)
Related UK National News Stories
Click here for the latest headlines.
01 March 2005
Alzheimer's drugs could be withdrawn
The National Institute of Clinical Excellence (NICE) has recommended the withdrawal of three drugs frequently used to help treat the symptoms of Alzheimer's disease.
Alzheimer's drugs could be withdrawn
The National Institute of Clinical Excellence (NICE) has recommended the withdrawal of three drugs frequently used to help treat the symptoms of Alzheimer's disease.
15 April 2008
Court Battle Over Alzheimer's Drug
Almost 100,000 patients a year suffering from Alzheimer's will be refused drugs used by the NHS to fight the disease, the Court of Appeal has been told. Drugs company EISAI, manufacturer of Aricept, is contesting a decision to restrict access to patients in the later stages of the disease.
Court Battle Over Alzheimer's Drug
Almost 100,000 patients a year suffering from Alzheimer's will be refused drugs used by the NHS to fight the disease, the Court of Appeal has been told. Drugs company EISAI, manufacturer of Aricept, is contesting a decision to restrict access to patients in the later stages of the disease.
25 June 2007
Court challenge over Alzheimer's drugs
A decision by the government's medicines watchdog to refuse to fund Alzheimer's drugs for patients in the early stages of the disease is being challenged in the High Court. The action has been brought by two drugs companies - Easai and Pfizer - as well as the Alzheimer's Society.
Court challenge over Alzheimer's drugs
A decision by the government's medicines watchdog to refuse to fund Alzheimer's drugs for patients in the early stages of the disease is being challenged in the High Court. The action has been brought by two drugs companies - Easai and Pfizer - as well as the Alzheimer's Society.
23 January 2006
Anger over Alzheimer's drugs ruling
The revised guidance on drugs for the treatment of Alzheimer's disease has been greeted with anger by Alzheimer's charities.
Anger over Alzheimer's drugs ruling
The revised guidance on drugs for the treatment of Alzheimer's disease has been greeted with anger by Alzheimer's charities.
05 July 2012
New Guidance On Rape Charges Won By Victims Family
The family of a nurse killed by her former partner while he was on bail for raping her has won a campaign to change legal guidance, meaning murderers who commit rape can be charged for both.
New Guidance On Rape Charges Won By Victims Family
The family of a nurse killed by her former partner while he was on bail for raping her has won a campaign to change legal guidance, meaning murderers who commit rape can be charged for both.
-
Northern Ireland WeatherToday:A showery start with outbreaks most frequent north of Lough Neagh and through the morning, before dwindling during the afternoon as the northwest breezes ease and brighter spells of weak sunshine prosper. Maximum temperature 8 °C.Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.
